Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MARX Biotech CoROCO:7731 -3.18%10 PB Ratio is 7.08 as of Jul. 17, 2026, which is 42% below its 10-year median of 12.16. GuruFocus rates ROCO:7731 with a GF Score™ of 10/100. The stock has 4 warning signs investors should review. Among 610 Healthcare Providers & Services companies, MARX Biotech Co ranks worse than 88.52% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-17), MARX Biotech Co's share price is NT$4.87. MARX Biotech Co's Book Value per Share for the quarter that ended in Dec. 2025 was NT$0.69. Hence, MARX Biotech Co's PB Ratio of today is 7.08.
The historical rank and industry rank for MARX Biotech Co's PB Ratio or its related term are showing as below:
ROCO:7731'
s PB Ratio Range Over the Past 10 Years
Min: 6.08 Med: 12.16 Max: 23.57
Current: 7.09
During the past 6 years, MARX Biotech Co's highest PB Ratio was 23.57. The lowest was 6.08. And the median was 12.16.
ROCO:7731's PB Ratio is ranked worse than 88.52% of 610
companies
in the Healthcare Providers & Services industry
Industry Median: 2.025
vs ROCO:7731: 7.09
During the past 12 months, MARX Biotech Co's average Book Value Per Share Growth Rate was 39.00% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 78.00% per year.
During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of MARX Biotech Co was 78.00% per year. The lowest was 55.80% per year. And the median was 66.90% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
MARX Biotech Co PB Ratio Related Terms
MARX Biotech Co PB Ratio Historical Data
* Premium members only.
The historical data trend for MARX Biotech Co's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, MARX Biotech Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MARX Biotech Co PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MARX Biotech Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where MARX Biotech Co's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
MARX Biotech Co's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
MARX Biotech Co (ROCO:7731) has a PB Ratio of 7.08 as of Jul. 17, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on MARX Biotech Co and its competitors. This is 42% below median its historical median of 12.16. Over the past decade, MARX Biotech Co's PB Ratio has ranged from 6.08 to 23.57. According to the industry distribution chart, MARX Biotech Co ranks #540 out of 610 companies in the Healthcare Providers & Services industry, placing it in the top 88.5%.
Is MARX Biotech Co's PB Ratio too high?
MARX Biotech Co's current PB Ratio of 7.08 is 42% below median its 10-year median of 12.16. Over the past 10 years, this metric has ranged from a low of 6.08 to a high of 23.57. The Healthcare Providers & Services industry median PB Ratio is 2.03. MARX Biotech Co's value of 7.08 is 249.6% above this industry median. Based on the distribution chart, MARX Biotech Co ranks #540 out of 610 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, MARX Biotech Co has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does MARX Biotech Co's PB Ratio compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, MARX Biotech Co ranks #540 out of 610 companies for PB Ratio. This places MARX Biotech Co in the lower half of its industry. The industry median PB Ratio is 2.03. MARX Biotech Co's value of 7.08 is 249.6% above this benchmark. Historically, MARX Biotech Co's own PB Ratio has ranged from 6.08 to 23.57 over the past decade. While the company's 10-year median is 12.16 vs. the industry median of 2.03, MARX Biotech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 2.03, based on 610 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MARX Biotech Co's current PB Ratio of 7.08 is 249.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on MARX Biotech Co and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 2.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MARX Biotech Co's current PB Ratio is 7.08, which is 42% below median its own 10-year median of 12.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MARX Biotech Co stock overvalued right now?
MARX Biotech Co (ROCO:7731) has a current PB Ratio of 7.08. The current PB Ratio is 7.08, which is 42% below median its 10-year median of 12.16 and 249.6% above the Healthcare Providers & Services industry median of 2.03. MARX Biotech Co's overall GF Score™ is 10/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For MARX Biotech Co (ROCO:7731), the current PB Ratio is 7.08 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
MARX Biotech Co Ltd is a retail company which has developed an O2O and OMO full-channel layout in the online Internet platform and cosmeceutical retail market, and has successfully established itself in the market and Build trust and operational growth on the channel side. It has has established more than three thousand large and small cosmeceutical pharmacies in Taiwan, including: Dashu Pharmacy, Dingding Pharmacy, Cosmed, Watsons, Spring Pharmacy, New Gaoqiao Pharmacy, Anlier Pharmacies, etc.
10GF Score
Get the complete analysis for ROCO:7731
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7731 has been successfully added to your 
